U.S. Appeals Court Invalidates Acorda Patents on MS Drug U.S. Appeals Court Invalidates Acorda Patents on MS Drug

A U.S. appeals court on Monday invalidated Acorda Therapeutics Inc patents covering its multiple sclerosis drug Ampyra, opening the door to generic competition for the company ' s flagship product.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Medscape Today News Source Type: news